Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
35 hedge funds and large institutions have $42.2M invested in Biolase, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
27% more capital invested
Capital invested by funds: $33.3M → $42.2M (+$8.94M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 34 → 35 (+1)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
97% less call options, than puts
Call options by funds: $1K | Put options by funds: $34K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$5.15M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$452K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$198K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$170K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$594K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$339K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$311K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$226K |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$217K |
BIOL Hedge Fund Activity: Q3 2014 in Review
35 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2014, worth a combined $42.2M — up 27% from $33.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIOL positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Oracle Investment Management, adding an estimated $5.15M. The largest seller was Northern Trust, cutting an estimated $594K.
- 35 institutional investors held Biolase, Inc. (BIOL) as of Q3 2014, up from 34 in Q2 2014.
- Funds reported $42.2M of Biolase, Inc. stock for Q3 2014, up 27% quarter-over-quarter.
- 6 funds opened new Biolase, Inc. positions in Q3 2014 and 5 closed out, a net change of +1 holder.
- The largest Biolase, Inc. buyer in Q3 2014 was Oracle Investment Management, an estimated $5.15M added.
- The largest Biolase, Inc. seller in Q3 2014 was Northern Trust, an estimated $594K sold.
Based on aggregated 13F filings for Q3 2014.